Stempoint Capital’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Stempoint Capital's ADRX Position: Q3 2026 in Review
Stempoint Capital opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 52,000 shares worth $1.04M. The stake represents 0.19% of the portfolio and ranks #74 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Stempoint Capital held 52,000 shares of ADARx Pharmaceuticals worth $1.04M as of Q3 2026.
- ADARx Pharmaceuticals was a new Stempoint Capital position in Q3 2026.
- ADARx Pharmaceuticals made up 0.19% of Stempoint Capital's portfolio in Q3 2026, its #74 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.